Skip to content
DraconiticResearch
Search Sources API
194,226 studies31 sourcesUpdated 18 min ago
Peer-reviewedCC BYMedicine

Relapsed/refractory PBML complicated with failed platelet implantation and mixed infection after allo-HSCT : A case report

  • Ying He1
  • Fangyi Fan1
  • Yingling Zhou2
  • Wei Sun3
  • Guangcui He1
  • Yan Deng1
  • Hai Yi1
  1. 1Department of Hematology, Chinese People’s Liberation Army The General Hospital of Western Theater Command, Chengdu, Sichuan, China
  2. 2Department of Emergency Medicine, Chinese People’s Liberation Army The General Hospital of Western Theater Command, Chengdu, Sichuan, China
  3. 3Department of Laboratory Medicine, Chinese People’s Liberation Army The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Read full textPDFCite

Related

  1. Synergistic Activity of Venetoclax and Rituximab in Multiply Relapsed or Refractory Waldenström Macroglobulinaemia
    Angeline Josiah, Ryan Low, Alisha Ganesh +5
    EJHaemPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. On closing the gap: anti-PD-1-based salvage in relapsed/ refractory classical Hodgkin lymphoma. Comment on: “Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma”
    Hishan Tharmaseelan, Bastian von Tresckow
    HaematologicaPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  3. Effectiveness and safety of treatments for new-onset, refractory and relapsed vitreoretinal lymphoma: protocol for a systematic review and network meta-analysis.
    Melissa K Shields, Richard J Woodman, Stewart R Lake +2
    BMJ openPeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref
  4. Biomarker-Targeted O6-Guanine Alkylation Potentiates ATR Inhibitor Response in De Novo and Relapsed/Refractory AML
    P. Bhardwaj, A. Baassiri, R. K. Sundaram +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. 556 A phase I first-in-human trial of IL-12 genetically engineered myeloid cells in participants with relapsed, refractory solid tumors
    Steven Highfill, Sabina Kaczanowska, Jessica Lake +4
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYImmunologyOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{he2026relapsedrefractory,
  title = {{Relapsed/refractory PBML complicated with failed platelet implantation and mixed infection after allo-HSCT : A case report}},
  author = {Ying He and Fangyi Fan and Yingling Zhou and Wei Sun and Guangcui He and Yan Deng and Hai Yi},
  journal = {Medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13657572},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Relapsed/refractory PBML complicated with failed platelet implantation and mixed infection after allo-HSCT : A case report
AU  - Ying He
AU  - Fangyi Fan
AU  - Yingling Zhou
AU  - Wei Sun
AU  - Guangcui He
AU  - Yan Deng
AU  - Hai Yi
PY  - 2026
DA  - 2026/10/09
JO  - Medicine
UR  - https://europepmc.org/article/PMC/PMC13657572
SN  - 0304-5412
SN  - 1536-5964
ER  -